Tobacco Use Treatment into Cancer Care


Title:  Integrating Tobacco Use Treatment into Cancer Care

Principal Investigator: Jamie Ostroff, PhD, Chief, Behavioral Sciences Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center

Overview: The purpose of this study is to compare two smoking cessation treatments in smokers who are receiving treatment at Memorial Sloan Kettering Cancer Center. One treatment approach includes our current standard of smoking cessation counseling. The second approach involves intensive smoking cessation counseling and includes additional counseling sessions, such as those focusing on smoking relapse and support after cancer treatment. Participants in both groups are offered the opportunity to use smoking cessation medications, such as varenicline or nicotine replacement. Those who are in the standard care group will pay for these medications themselves, while those in the intensive treatment group who choose to take these medications will receive them free of charge.